Patent · US Active

H3.3 CTL peptides and uses thereof

US10849965B2 · kind B2 · utility

2Cited by

28References

18Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Hideho Okada · Mill Valley, US
Yafei Hou · Palo Alto, US

Key dates

Filing date	Sep 12, 2019
Grant date	Dec 1, 2020
Priority date	—
Expiry date	Sep 12, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2239/47
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Peptides that generate an immune response to glioma-related H3.3 proteins and methods of their use are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.